L4E rule 7-8 (2014) - Revision history

Michael: /* See also */

2019-05-20T01:10:55Z

2017-10-25T05:44:37Z

Details

← Older revision		Revision as of 05:44, 25 October 2017
Line 23:		Line 23:
	\| All specimen types		\| All specimen types
	\| 0.5 L4E/onerous special stain		\| 0.5 L4E/onerous special stain
	\| includes only time consuming special stains: [[Warthin-Starry stain]], [[ZN stain]], [[Fite stain]]; if the stain is done upfront/routinely by the lab it is not counted ‡		\| includes only time consuming special stains: [[Warthin-Starry stain]], [[ZN stain]], [[Fite stain]]; stain must be ordered by pathologist - if the stain is done upfront/routinely by the lab it is not counted ‡
	\| one lung core biopsy with granulomas - ZN, GMS, PASD done = 1 ([[L4E rule 1\|rule 1]]) + 0.5 + 2 x 0.15 L4E		\| one lung core biopsy with granulomas - ZN, GMS, PASD done = 1 ([[L4E rule 1\|rule 1]]) + 0.5 + 2 x 0.15 L4E
	\| Rule 7		\| Rule 7

2017-10-25T05:43:57Z

Details

← Older revision		Revision as of 05:43, 25 October 2017
Line 16:		Line 16:
	\|-		\|-
	\| All specimen types		\| All specimen types
	\| 0.15 L4E/[[Quality#Classification_of_IHC_tests\|class 1 immunostain]] slide, 0.15 L4E/non-onerous special ~~stains~~		\| 0.15 L4E/[[Quality#Classification_of_IHC_tests\|class 1 immunostain]] slide, 0.15 L4E/non-onerous special stain
	\| does '''not''' include [[Quality#Classification_of_IHC_tests\|class 2 IHC test]]s † (e.g. ER/PR/HER2 for breast ca), does '''not''' include so called ''onerous special stains'' (see below), 1 IHC = 0.33 L4E, 2 IHC = 0.66 L4E, 3 IHC = 1 L4E ...		\| does '''not''' include [[Quality#Classification_of_IHC_tests\|class 2 IHC test]]s † (e.g. ER/PR/HER2 for breast ca), does '''not''' include so called ''onerous special stains'' (see below), 1 IHC = 0.33 L4E, 2 IHC = 0.66 L4E, 3 IHC = 1 L4E ...
	\| 2 lung cores with CRC demonstrated with 5 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 5 x 0.15 L4E		\| 2 lung cores with CRC demonstrated with 5 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 5 x 0.15 L4E

2017-10-25T05:43:26Z

Details

← Older revision		Revision as of 05:43, 25 October 2017
Line 17:		Line 17:
	\| All specimen types		\| All specimen types
	\| 0.15 L4E/[[Quality#Classification_of_IHC_tests\|class 1 immunostain]] slide, 0.15 L4E/non-onerous special stains		\| 0.15 L4E/[[Quality#Classification_of_IHC_tests\|class 1 immunostain]] slide, 0.15 L4E/non-onerous special stains
	\| does '''not''' include [[Quality#Classification_of_IHC_tests\|class 2]] ~~IHC tests~~ † (e.g. ER/PR/HER2 for breast ca), does '''not''' include so called ''onerous special stains'' (see below), 1 IHC = 0.33 L4E, 2 IHC = 0.66 L4E, 3 IHC = 1 L4E ...		\| does '''not''' include [[Quality#Classification_of_IHC_tests\|class 2 IHC test]]s † (e.g. ER/PR/HER2 for breast ca), does '''not''' include so called ''onerous special stains'' (see below), 1 IHC = 0.33 L4E, 2 IHC = 0.66 L4E, 3 IHC = 1 L4E ...
	\| 2 lung cores with CRC demonstrated with 5 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 5 x 0.15 L4E		\| 2 lung cores with CRC demonstrated with 5 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 5 x 0.15 L4E
	\| Rule 7		\| Rule 7

2017-10-25T05:43:02Z

Details

← Older revision		Revision as of 05:43, 25 October 2017
Line 16:		Line 16:
	\|-		\|-
	\| All specimen types		\| All specimen types
	\| 0.15 L4E/[[[[Quality#Classification_of_IHC_tests\|class 1 immunostain]] slide, 0.15 L4E/non-onerous special stains		\| 0.15 L4E/[[Quality#Classification_of_IHC_tests\|class 1 immunostain]] slide, 0.15 L4E/non-onerous special stains
	\| does '''not''' include [[Quality#Classification_of_IHC_tests\|class 2]] IHC tests † (e.g. ER/PR/HER2 for breast ca), does '''not''' include so called ''onerous special stains'' (see below), 1 IHC = 0.33 L4E, 2 IHC = 0.66 L4E, 3 IHC = 1 L4E ...		\| does '''not''' include [[Quality#Classification_of_IHC_tests\|class 2]] IHC tests † (e.g. ER/PR/HER2 for breast ca), does '''not''' include so called ''onerous special stains'' (see below), 1 IHC = 0.33 L4E, 2 IHC = 0.66 L4E, 3 IHC = 1 L4E ...
	\| 2 lung cores with CRC demonstrated with 5 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 5 x 0.15 L4E		\| 2 lung cores with CRC demonstrated with 5 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 5 x 0.15 L4E

2017-10-25T05:42:54Z

Details

← Older revision		Revision as of 05:42, 25 October 2017
Line 16:		Line 16:
	\|-		\|-
	\| All specimen types		\| All specimen types
	\| 0.15 L4E/class 1 immunostain slide, 0.15 L4E/non-onerous special stains		\| 0.15 L4E/[[[[Quality#Classification_of_IHC_tests\|class 1 immunostain]] slide, 0.15 L4E/non-onerous special stains
	\| does '''not''' include [[Quality#Classification_of_IHC_tests\|class 2]] IHC tests † (e.g. ER/PR/HER2 for breast ca), does '''not''' include so called ''onerous special stains'' (see below), 1 IHC = 0.33 L4E, 2 IHC = 0.66 L4E, 3 IHC = 1 L4E ...		\| does '''not''' include [[Quality#Classification_of_IHC_tests\|class 2]] IHC tests † (e.g. ER/PR/HER2 for breast ca), does '''not''' include so called ''onerous special stains'' (see below), 1 IHC = 0.33 L4E, 2 IHC = 0.66 L4E, 3 IHC = 1 L4E ...
	\| 2 lung cores with CRC demonstrated with 5 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 5 x 0.15 L4E		\| 2 lung cores with CRC demonstrated with 5 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 5 x 0.15 L4E

2017-10-25T05:42:09Z

Details

← Older revision		Revision as of 05:42, 25 October 2017
Line 29:		Line 29:
	\| All specimen types		\| All specimen types
	\| 0.33 L4E/immunofluorescent stain		\| 0.33 L4E/immunofluorescent stain
	\|		\| applies only to immunofluorescent stains (IFs)
	\| skin biopsy with 4 IFs = 1 L4E ([[L4E rule 1\|rule 1]]) + 4 x 0.33 L4E		\| skin biopsy with 4 IFs = 1 L4E ([[L4E rule 1\|rule 1]]) + 4 x 0.33 L4E
	\| Rule 7		\| Rule 7

2017-10-25T05:10:41Z

Details

← Older revision		Revision as of 05:10, 25 October 2017
Line 35:		Line 35:
	\| All specimen types		\| All specimen types
	\| 0.5 L4E/class 2 immunostain slide		\| 0.5 L4E/class 2 immunostain slide
	\| does '''not''' apply to ER done ~~for~~ diagnostic ~~purposes~~, e.g. ~~demonstrating~~ metastatic breast ca in a vertebra body		\| does '''not''' apply to IHCs done in a diagnostic context, e.g. using ER to demonstrate metastatic breast ca in a vertebra body
	\| 2 breast cores with ER/PR/HER2 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 3 x 0.5 L4E		\| 2 breast cores with ER/PR/HER2 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 3 x 0.5 L4E
	\| Rule 8		\| Rule 8

2017-10-25T05:09:54Z

Details

← Older revision		Revision as of 05:09, 25 October 2017
Line 35:		Line 35:
	\| All specimen types		\| All specimen types
	\| 0.5 L4E/class 2 immunostain slide		\| 0.5 L4E/class 2 immunostain slide
	\|		\| does '''not''' apply to ER done for diagnostic purposes, e.g. demonstrating metastatic breast ca in a vertebra body
	\| 2 breast cores with ER/PR/HER2 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 3 x 0.5 L4E		\| 2 breast cores with ER/PR/HER2 IHC = 1 L4E ([[L4E rule 1\|rule 1]]) + 3 x 0.5 L4E
	\| Rule 8		\| Rule 8

2017-10-25T05:07:54Z

Overview

← Older revision		Revision as of 05:07, 25 October 2017
Line 5:		Line 5:
	==Overview==		==Overview==
	*Rule 7 applies to specimens with additional stains and/or diagnostic ([[Quality#Classification_of_IHC_tests\|class 1]]) immunostains requested by the pathologist.		*Rule 7 applies to specimens with additional stains and/or diagnostic ([[Quality#Classification_of_IHC_tests\|class 1]]) immunostains requested by the pathologist.
	*Rule 8 applies to specimens with class 2 immunostains (e.g. ER/PR/HER2 for breast cancer).		*Rule 8 applies to specimens with [[Quality#Classification_of_IHC_tests\|class 2 immunostains]] (e.g. ER/PR/HER2 for breast cancer).

	==Details==		==Details==